Cases & Deals

Celularity raises capital in Series B round

Clients Celularity Inc.

Jones Day represented Celularity Inc., a biotechnology company that sources and develops transformative therapies derived from the placenta, in connection with its Series B Preferred Stock financing.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.